HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Breast cancer cell survival signal is affected by bergapten combined with an ultraviolet irradiation.

Abstract
In this study we have reported that bergapten (B) and bergapten plus UV (PUVA) are able to significantly affect MCF-7, ZR-75 and SKBR-3 breast cancer cell proliferations. B induced a lowering of PI3K/AKT survival signal in MCF-7 cells even in presence of IGF-I stimulation. Furthermore, B and in a higher extent, PUVA up-regulated the p53 mRNA and the protein content. An increased co-association between p21 WAF and proliferating cell nuclear antigen (PCNA) has been observed in PUVA-treated MCF-7 cells, thus inhibiting DNA replication. These results highlight how B, and its photoactivated compound, exert antiproliferative effects and induce apoptotic responses in breast cancer cells.
AuthorsMaria Luisa Panno, Francesca Giordano, Fabrizia Mastroianni, M Grazia Palma, Viviana Bartella, Amalia Carpino, Saveria Aquila, Sebastiano Andò
JournalFEBS letters (FEBS Lett) Vol. 584 Issue 11 Pg. 2321-6 (Jun 03 2010) ISSN: 1873-3468 [Electronic] England
PMID20371365 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Chemical References
  • Photosensitizing Agents
  • Proliferating Cell Nuclear Antigen
  • Tumor Suppressor Protein p53
  • 5-Methoxypsoralen
  • Insulin-Like Growth Factor I
  • Proto-Oncogene Proteins c-akt
  • Methoxsalen
Topics
  • 5-Methoxypsoralen
  • Breast Neoplasms (drug therapy, genetics)
  • Cell Line, Tumor
  • Cell Survival (drug effects)
  • Humans
  • Insulin-Like Growth Factor I (pharmacology)
  • Methoxsalen (analogs & derivatives, pharmacology)
  • Photosensitizing Agents (pharmacology)
  • Proliferating Cell Nuclear Antigen (metabolism)
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Radiation
  • Signal Transduction (drug effects)
  • Tumor Suppressor Protein p53 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: